MedTrace Logo

Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine

NCT00542776 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2008-05-01

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical controls.

Conditions

  • Inflammatory Bowel Disease (IBD)
  • Immunosuppressed or Non-Immunosuppressed
  • Influenza Vaccine
  • Antibody Titers
  • Seroprotective Titers

Interventions

OTHER

blood draw

drawing blood for seroprotection and antibody titers to the 3 strains of influenza on Day 1 and Month 1 (3-8 weeks)

Sponsors & Collaborators

Principal Investigators

  • Ying Lu, MD · Boston Children's Hospital

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00542776 on ClinicalTrials.gov